Breast cancer treatment is based on prognostic and predictive factors such as tumor stage, histological grade, proliferation, the pattern of hormonal receptor expression (ER, estrogen receptor; PgR, progesterone receptor) and HER2 amplification (Human epidermal growth factor receptor 2). This evidence concerns the gene ESR1 and neoplasm.